Works matching AU Ahn, Myung-Ju

Results: 150

Biomarker-driven phase 2 umbrella trial study for patients with recurrent small cell lung cancer failing platinum-based chemotherapy.

Published in:

2020

By:

Park, Sehhoon;
Shim, Joonho;
Mortimer, Peter G. S.;
Smith, Simon A.;
Godin, Robert E.;
Hollingsworth, Simon J.;
Kim, Hee‐Jung;
Jung, Hyun Ae;
Sun, Jong‐Mu;
Park, Woong‐Yang;
Ahn, Jin Seok;
Ahn, Myung‐Ju;
Lee, Se‐Hoon;
Park, Keunchil;
Kim, Hee-Jung;
Sun, Jong-Mu;
Park, Woong-Yang;
Ahn, Myung-Ju;
Lee, Se-Hoon

Publication type:

journal article

Genomic landscape of acquired resistance to third-generation EGFR tyrosine kinase inhibitors in EGFR T790M-mutant non-small cell lung cancer.

Published in:

2020

By:

Lee, Jiyun;
Kim, Hong Sook;
Lee, Boram;
Kim, Hee Kyung;
Sun, Jong‐Mu;
Ahn, Jin Seok;
Ahn, Myung‐Ju;
Park, Keunchil;
Lee, Se‐Hoon;
Sun, Jong-Mu;
Ahn, Myung-Ju;
Lee, Se-Hoon

Publication type:

journal article

Osimertinib in patients with T790M mutation-positive, advanced non-small cell lung cancer: Long-term follow-up from a pooled analysis of 2 phase 2 studies.

Published in:

2019

By:

Ahn, Myung‐Ju;
Tsai, Chun‐Ming;
Shepherd, Frances A.;
Bazhenova, Lyudmila;
Sequist, Lecia V.;
Hida, Toyoaki;
Yang, James C. H.;
Ramalingam, Suresh S.;
Mitsudomi, Tetsuya;
Jänne, Pasi A.;
Mann, Helen;
Cantarini, Mireille;
Goss, Glenwood;
Ahn, Myung-Ju;
Tsai, Chun-Ming

Publication type:

journal article

Diagnostic accuracy of MR imaging of patients with leptomeningeal seeding from lung adenocarcinoma based on 2017 RANO proposal: added value of contrast-enhanced 2D axial T2 FLAIR.

Published in:

Journal of Neuro-Oncology, 2020, v. 149, n. 2, p. 367, doi. 10.1007/s11060-020-03617-2

By:

Seong, Minjung;
Park, Sehhoon;
Kim, Sung Tae;
Park, Sung Goo;
Kim, Yi Kyung;
Kim, Hyung-Jin;
Ahn, Myung-Ju

Publication type:

Article

Outcome of gamma knife radiosurgery for metastatic brain tumors derived from non-small cell lung cancer.

Published in:

Journal of Neuro-Oncology, 2015, v. 125, n. 2, p. 331, doi. 10.1007/s11060-015-1915-x

By:

Cho, Kyung;
Lee, Min;
Kong, Doo-Sik;
Seol, Ho;
Nam, Do-Hyun;
Sun, Jong-Mu;
Ahn, Jin;
Ahn, Myung-Ju;
Park, Keunchil;
Kim, Sung;
Lim, Do;
Lee, Jung-Il

Publication type:

Article

Real-world outcomes of anti-PD1 antibodies in platinum-refractory, PD-L1-positive recurrent and/or metastatic non-small cell lung cancer, and its potential practical predictors: first report from Korean Cancer Study Group LU19-05.

Published in:

Journal of Cancer Research & Clinical Oncology, 2021, v. 147, n. 8, p. 2459, doi. 10.1007/s00432-021-03527-4

By:

Park, Ji Hyun;
You, Gun Lyung;
Ahn, Myung-Ju;
Kim, Sang-We;
Hong, Min Hee;
Han, Ji-Youn;
Ock, Chan-Young;
Lee, Jong-Seok;
Oh, In Jae;
Lee, Shin Yup;
Kim, Cheol Hyeon;
Min, Young Joo;
Choi, Yoon Hee;
Ryu, Jeong-Seon;
Park, Sun Hyo;
Ahn, Hee Kyung;
Shim, Byoung-Yong;
Lee, Ki Hyeong;
Lee, Sung Yong;
Kim, Jin-Soo

Publication type:

Article

Correction to: Hyperprogressive disease and its clinical impact in patients with recurrent and/or metastatic head and neck squamous cell carcinoma treated with immune-checkpoint inhibitors: Korean cancer study group HN 18–12.

Published in:

2020

By:

Park, Ji Hyun;
Chun, Sang Hoon;
Lee, Yun-Gyoo;
Chang, Hyun;
Lee, Keun-Wook;
Kim, Hye Ryun;
Shin, Seong Hoon;
An, Ho Jung;
Lee, Kyoung Eun;
Hwang, In Gyu;
Ahn, Myung-Ju;
Kim, Sung-Bae;
Keam, Bhumsuk

Publication type:

Correction Notice

Hyperprogressive disease and its clinical impact in patients with recurrent and/or metastatic head and neck squamous cell carcinoma treated with immune-checkpoint inhibitors: Korean cancer study group HN 18–12.

Published in:

Journal of Cancer Research & Clinical Oncology, 2020, v. 146, n. 12, p. 3359, doi. 10.1007/s00432-020-03316-5

By:

Park, Ji Hyun;
Chun, Sang Hoon;
Lee, Yun-Gyoo;
Chang, Hyun;
Lee, Keun-Wook;
Kim, Hye Ryun;
Shin, Seong Hoon;
An, Ho Jung;
Lee, Kyoung Eun;
Hwang, In Gyu;
Ahn, Myung-Ju;
Kim, Sung-Bae;
Keam, Bhumsuk

Publication type:

Article

Impact of EGFR mutation on the clinical efficacy of PD-1 inhibitors in patients with pulmonary adenocarcinoma.

Published in:

Journal of Cancer Research & Clinical Oncology, 2019, v. 145, n. 5, p. 1341, doi. 10.1007/s00432-019-02889-0

By:

Cho, Jang Ho;
Jung, Hyun Ae;
Lee, Se-Hoon;
Ahn, Jin Seok;
Ahn, Myung-Ju;
Park, Keunchil;
Sun, Jong-Mu

Publication type:

Article

Quality of Life With Pembrolizumab for Recurrent and/or Metastatic Head and Neck Squamous Cell Carcinoma: KEYNOTE-040.

Published in:

2021

By:

Harrington, Kevin J;
Soulières, Denis;
Tourneau, Christophe Le;
Dinis, Jose;
Licitra, Lisa F;
Ahn, Myung-Ju;
Soria, Ainara;
Machiels, Jean-Pascal H;
Mach, Nicolas;
Mehra, Ranee;
Burtness, Barbara;
Ellison, Misoo C;
Cheng, Jonathan D;
Chirovsky, Diana Romana;
Swaby, Ramona F;
Cohen, Ezra E W;
Le Tourneau, Christophe

Publication type:

journal article

Top 20 EGFR+ NSCLC Clinical and Translational Science Papers That Shaped the 20 Years Since the Discovery of Activating EGFR Mutations in NSCLC. An Editor-in-Chief Expert Panel Consensus Survey.

Published in:

Lung Cancer: Targets & Therapy, 2024, v. 15, p. 87, doi. 10.2147/LCTT.S463429

By:

Ou, Sai-Hong Ignatius;
Le, Xiuning;
Nagasaka, Misako;
Reungwetwattana, Thanyanan;
Ahn, Myung-Ju;
Lim, Darren WT;
Santos, Edgardo S;
Shum, Elaine;
Lau, Sally CM;
Lee, Jii Bum;
Calles, Antonio;
Wu, Fengying;
Lopes, Gilberto;
Sriuranpong, Virote;
Tanizaki, Junko;
Horinouchi, Hidehito;
Garassino, Marina C;
Popat, Sanjay;
Besse, Benjamin;
Rosell, Rafael

Publication type:

Article

Pretreatment Clinical Mediastinal Nodal Bulk and Extent do not Influence Survival in N2-Positive Stage IIIA Non-small Cell Lung Cancer Patients Treated with Trimodality Therapy.

Published in:

Annals of Surgical Oncology: An Oncology Journal for Surgeons, 2014, v. 21, n. 6, p. 2083, doi. 10.1245/s10434-014-3540-x

By:

Lee, Hyebin;
Ahn, Yong;
Pyo, Hongryull;
Kim, BoKyong;
Oh, Dongryul;
Nam, Heerim;
Lee, Eunju;
Sun, Jong-Mu;
Ahn, Jin;
Ahn, Myung-Ju;
Park, Keunchil;
Choi, Yong;
Kim, Jhingook;
Zo, Jae;
Shim, Young

Publication type:

Article

Volume-Based Parameter of F-FDG PET/CT in Malignant Pleural Mesothelioma: Prediction of Therapeutic Response and Prognostic Implications.

Published in:

Annals of Surgical Oncology: An Oncology Journal for Surgeons, 2010, v. 17, n. 10, p. 2787, doi. 10.1245/s10434-010-1107-z

By:

Lee, Ho;
Hyun, Seung;
Lee, Kyung;
Kim, Byung-Tae;
Kim, Jhingook;
Shim, Young;
Ahn, Myung-Ju;
Kim, Tae;
Yi, Chin;
Chung, Myung

Publication type:

Article

Prognostic value of SUVmax on 18F-fluorodeoxyglucose PET/CT scan in patients with malignant pleural mesothelioma.

Published in:

PLoS ONE, 2020, v. 15, n. 2, p. 1, doi. 10.1371/journal.pone.0229299

By:

Lim, Jun Hyeok;
Choi, Joon Young;
Im, Yunjoo;
Yoo, Hongseok;
Jhun, Byung Woo;
Jeong, Byeong-Ho;
Park, Hye Yun;
Lee, Kyungjong;
Kim, Hojoong;
Kwon, O Jung;
Han, Joungho;
Ahn, Myung-Ju;
Kim, Jhingook;
Um, Sang-Won

Publication type:

Article

Outcomes of Curative-Intent Surgery and Adjuvant Treatment for Pulmonary Large Cell Neuroendocrine Carcinoma.

Published in:

World Journal of Surgery, 2017, v. 41, n. 7, p. 1820, doi. 10.1007/s00268-017-3908-8

By:

Kim, Kun;
Kim, Hong;
Kim, Jhingook;
Shim, Young;
Ahn, Myung-Ju;
Choi, Yoon-La

Publication type:

Article

DNA flow cytometry of stomach cancer. Prospective correlation with clinicopathologic findings.

Published in:

1993

By:

Lee, Kyoo Hyung;
Lee, Jung Shin;
Suh, Cheolwon;
Ahn, Myung Ju;
Kim, Sang We;
Doh, Byung Soon;
Min, Young Ii;
Kim, Byung Sik;
Park, Kun Choon;
Lee, In Cheol;
Cho, Young Joo;
Choi, Mi Gyoung;
Kim, Sang-Hee;
Lee, K H;
Lee, J S;
Suh, C;
Ahn, M J;
Kim, S W;
Doh, B S;
Min, Y I

Publication type:

journal article

Characteristics and outcomes of ALK+ non-small cell lung cancer patients in Korea.

Published in:

Asia Pacific Journal of Clinical Oncology, 2017, v. 13, n. 5, p. e239, doi. 10.1111/ajco.12645

By:

Lim, Sung Hee;
Yoh, Kyung Ah;
Lee, Jong Seok;
Ahn, Myung‐ju;
Kim, Yu Jung;
Kim, Se Hyun;
Zhang, Jie;
Patel, Dony;
Swallow, Elyse;
Kageleiry, Andrew;
Galebach, Philip;
Lee, Dongyeol;
Stein, Karen;
Degun, Ravi;
Park, Keunchil

Publication type:

Article

An East Asian subgroup analysis of PROCLAIM, a phase III trial of pemetrexed and cisplatin or etoposide and cisplatin plus thoracic radiation therapy followed by consolidation chemotherapy in locally advanced nonsquamous non-small cell lung cancer.

Published in:

Asia Pacific Journal of Clinical Oncology, 2016, v. 12, n. 4, p. 380, doi. 10.1111/ajco.12513

By:

Wang, Luhua;
Wu, Yi‐Long;
Lu, Shun;
Deng, Lei;
Ahn, Myung‐Ju;
Hsu, Feng‐Ming;
Iscoe, Neill;
Hossain, Anwar;
Puri, Tarun;
Zhang, Pinghai;
Orlando, Mauro

Publication type:

Article

Phase II Study of Afatinib as Third-Line Treatment for Patients in Korea With Stage IIIB/IV Non-Small Cell Lung Cancer Harboring Wild-Type EGFR.

Published in:

Oncologist, 2014, v. 19, n. 7, p. 702, doi. 10.1634/theoncologist.2013-0419

By:

Ahn, Myung‐Ju;
Kim, Sang‐We;
Cho, Byoung‐Chul;
Ahn, Jin Seok;
Lee, Dae Ho;
Sun, Jong‐Mu;
Massey, Dan;
Kim, Miyoung;
Shi, Yang;
Park, Keunchil

Publication type:

Article

Exome sequencing reveals recurrent REV3L mutations in cisplatin-resistant squamous cell carcinoma of head and neck.

Published in:

Scientific Reports, 2016, p. 19552, doi. 10.1038/srep19552

By:

Huang, Kie Kyon;
Jang, Kang Won;
Kim, Sangwoo;
Kim, Han Sang;
Kim, Sung-Moo;
Kwon, Hyeong Ju;
Kim, Hye Ryun;
Yun, Hwan Jung;
Ahn, Myung Ju;
Park, Keon Uk;
Ramnarayanan, Kalpana;
McPherson, John R.;
Zhang, Shenli;
Rhee, Je-Keun;
Vettore, André L.;
Das, Kakoli;
Ishimoto, Takatsugu;
Kim, Joo Hang;
Koh, Yoon Woo;
Kim, Se Hun

Publication type:

Article

Association between Tumor Size at the Time of Disease Progression and Survival Outcomes.

Published in:

Cancer Research & Treatment, 2025, v. 57, n. 2, p. 362, doi. 10.4143/crt.2024.690

By:

Maeng, Chi Hoon;
Kim, Bum Jun;
Ahn, Myung-Ju;
Choi, In Sil;
Zang, Dae Young;
Kim, Bo-Hyung;
Kwon, Minji;
Heo, Dae Seog;
Keam, Bhumsuk

Publication type:

Article

The Survival and Financial Benefit of Investigator-Initiated Trials Conducted by Korean Cancer Study Group.

Published in:

Cancer Research & Treatment, 2025, v. 57, n. 1, p. 39, doi. 10.4143/crt.2024.421

By:

Kim, Bum Jun;
Maeng, Chi Hoon;
Keam, Bhumsuk;
Im, Young-Hyuck;
Ro, Jungsil;
Jung, Kyung Hae;
Im, Seock-Ah;
Kim, Tae Won;
Lee, Jae Lyun;
Heo, Dae Seog;
Kim, Sang-We;
Park, Keunchil;
Ahn, Myung-Ju;
Cho, Byoung Chul;
Kim, Hoon-Kyo;
Kang, Yoon-Koo;
Cho, Jae Yong;
Yun, Hwan Jung;
Nam, Byung-Ho;
Zang, Dae Young

Publication type:

Article

Adjuvant Pembrolizumab in Patients with Stage IIIA/N2 Non–Small Cell Lung Cancer Completely Resected after Neoadjuvant Concurrent Chemoradiation: A Prospective, Open-Label, Single-Arm, Phase 2 Trial.

Published in:

Cancer Research & Treatment, 2024, v. 56, n. 4, p. 1084, doi. 10.4143/crt.2024.084

By:

Shin, Junghoon;
Park, Sehhoon;
Kim, Kyung Hwan;
Shin, Eui-Cheol;
Jung, Hyun Ae;
Cho, Jong Ho;
Sun, Jong-Mu;
Lee, Se-Hoon;
Choi, Yong Soo;
Ahn, Jin Seok;
Kim, Jhingook;
Park, Keunchil;
Shim, Young Mog;
Kim, Hong Kwan;
Noh, Jae Myoung;
Ahn, Yong Chan;
Pyo, Hongryull;
Ahn, Myung-Ju

Publication type:

Article

Analysis of Response and Progression Patterns of Tyrosine Kinase Inhibitors in Recurrent or Metastatic Adenoid Cystic Carcinoma: A Post Hoc Analysis of Two KCSG Phase II Trials.

Published in:

Cancer Research & Treatment, 2024, v. 56, n. 4, p. 1068, doi. 10.4143/crt.2024.008

By:

Kim, Youjin;
Keam, Bhumsuk;
Kang, Eun Joo;
Kim, Jin-Soo;
Kim, Hye Ryun;
Lee, Keun-Wook;
Kwon, Jung Hye;
Lee, Kyoung Eun;
Yang, Yaewon;
Choi, Yoon Hee;
Kim, Min Kyoung;
Ji, Jun Ho;
Yun, Tak;
Choi, Moon Young;
Lee, Ki Hyeong;
Kim, Sung-Bae;
Ahn, Myung-Ju

Publication type:

Article

Combination of Dabrafenib and Trametinib in Patients with Metastatic BRAF<sup>V600E</sup>-Mutated Thyroid Cancer.

Published in:

Cancer Research & Treatment, 2024, v. 56, n. 4, p. 1270, doi. 10.4143/crt.2023.1278

By:

Jeon, Youngkyung;
Park, Sehhoon;
Lee, Se-Hoon;
Kim, Tae Hyuk;
Kim, Sun Wook;
Ahn, Myung-Ju;
Jung, Hyun Ae;
Chung, Jae Hoon

Publication type:

Article

Pralsetinib in Patients with Advanced/Metastatic Rearranged During Transfection (RET)-Altered Thyroid Cancer: Updated Efficacy and Safety Data from the ARROW Study.

Published in:

Thyroid, 2024, v. 34, n. 1, p. 26, doi. 10.1089/thy.2023.0363

By:

Subbiah, Vivek;
Hu, Mimi I.;
Mansfield, Aaron S.;
Taylor, Matthew H.;
Schuler, Martin;
Zhu, Viola W.;
Hadoux, Julien;
Curigliano, Giuseppe;
Wirth, Lori;
Gainor, Justin F.;
Alonso, Guzman;
Adkins, Douglas;
Godbert, Yann;
Ahn, Myung-Ju;
Cassier, Philippe A.;
Cho, Byoung Chul;
Lin, Chia-Chi;
Zalutskaya, Alena;
Barata, Teresa;
Trask, Peter

Publication type:

Article

Acquired resistance to AZD9291 as an upfront treatment is dependent on ERK signaling in a preclinical model.

Published in:

PLoS ONE, 2018, v. 13, n. 4, p. 1, doi. 10.1371/journal.pone.0194730

By:

Ku, Bo Mi;
Choi, Moon Ki;
Sun, Jong-Mu;
Lee, Se-Hoon;
Ahn, Jin Seok;
Park, Keunchil;
Ahn, Myung-Ju

Publication type:

Article

Osimertinib for the treatment of non-small cell lung cancer.

Published in:

Expert Opinion on Pharmacotherapy, 2017, v. 18, n. 2, p. 225, doi. 10.1080/14656566.2017.1285283

By:

Sun, Jong-Mu;
Lee, Se-Hoon;
Ahn, Jin Seok;
Park, Keunchil;
Ahn, Myung-Ju

Publication type:

Article

Phase I clinical trial of KML001 monotherapy in patients with advanced solid tumors.

Published in:

Expert Opinion on Investigational Drugs, 2020, v. 29, n. 9, p. 1059, doi. 10.1080/13543784.2020.1804855

By:

Kim, Seokuee;
Kim, Sujong;
Park, Young Suk;
Park, Joon Oh;
Lim, Ho Yeong;
Ahn, Jin Seok;
Lee, Jeeyun;
Sun, Jong Mu;
Kang, Won Ki;
Han, RaeO;
Kim, Jungryul;
Ahn, Myung-Ju

Publication type:

Article

Predicting Lung Cancer in Korean Never‐Smokers With Polygenic Risk Scores.

Published in:

Genetic Epidemiology, 2025, v. 49, n. 1, p. 1, doi. 10.1002/gepi.22586

By:

Kim, Juyeon;
Park, Young Sik;
Kim, Jin Hee;
Hong, Yun‐Chul;
Kim, Young‐Chul;
Oh, In‐Jae;
Jee, Sun Ha;
Ahn, Myung‐Ju;
Kim, Jong‐Won;
Yim, Jae‐Joon;
Won, Sungho

Publication type:

Article

Tumor infiltrated immune cell types support distinct immune checkpoint inhibitor outcomes in patients with advanced non‐small cell lung cancer.

Published in:

European Journal of Immunology, 2021, v. 51, n. 4, p. 956, doi. 10.1002/eji.202048966

By:

Ku, Bo Mi;
Kim, Youjin;
Lee, Kyoung Young;
Kim, Sang‐Yeob;
Sun, Jong‐Mu;
Lee, Se‐Hoon;
Ahn, Jin Seok;
Park, Keunchil;
Ahn, Myung‐Ju

Publication type:

Article

MDSC subtypes and CD39 expression on CD8<sup>+</sup> T cells predict the efficacy of anti‐PD‐1 immunotherapy in patients with advanced NSCLC.

Published in:

European Journal of Immunology, 2020, v. 50, n. 11, p. 1810, doi. 10.1002/eji.202048534

By:

Koh, Jiae;
Kim, Youjin;
Lee, Kyoung Young;
Hur, Joon Young;
Kim, Mi Soon;
Kim, Boram;
Cho, Hee Jin;
Lee, Yeong Chan;
Bae, Yeon Hee;
Ku, Bo Mi;
Sun, Jong‐Mu;
Lee, Se‐Hoon;
Ahn, Jin Seok;
Park, Keunchil;
Ahn, Myung‐Ju

Publication type:

Article

Risk Factors for Progressive Disease After Immune Checkpoint Inhibitor Therapy in Head and Neck Squamous Cell Carcinoma.

Published in:

Head & Neck, 2025, v. 47, n. 6, p. 1621, doi. 10.1002/hed.28071

By:

Jang, Seo Yoon;
Lee, Yun‐Gyoo;
Chun, Sang Hoon;
Park, Ji Hyun;
Park, Keon Uk;
Chang, Hyun;
Lee, Keun‐Wook;
Kim, Hye Ryun;
Shin, Seong Hoon;
An, Ho Jung;
Lee, Kyoung Eun;
Hwang, In Gyu;
Ahn, Myung‐Ju;
Kim, Sung‐Bae;
Keam, Bhumsuk

Publication type:

Article

Artificial intelligence‐powered spatial analysis of tumor‐infiltrating lymphocytes as a predictive biomarker for axitinib in adenoid cystic carcinoma.

Published in:

Head & Neck, 2023, v. 45, n. 12, p. 3086, doi. 10.1002/hed.27537

By:

Kim, Dong Hyun;
Lim, Yoojoo;
Ock, Chan‐Young;
Park, Gahee;
Park, Seonwook;
Song, Heon;
Ma, Minuk;
Mostafavi, Mohammad;
Kang, Eun Joo;
Ahn, Myung‐Ju;
Lee, Keun‐Wook;
Kwon, Jung Hye;
Yang, Yaewon;
Choi, Yoon Hee;
Kim, Min Kyoung;
Ji, Jun Ho;
Yun, Tak;
Kim, Sung‐Bae;
Keam, Bhumsuk

Publication type:

Article

Prevalence of NUT carcinoma in head and neck: Analysis of 362 cases with literature review.

Published in:

Head & Neck, 2020, v. 42, n. 5, p. 924, doi. 10.1002/hed.26067

By:

Lee, Taebum;
Cho, Junhun;
Baek, Chung‐Hwan;
Son, Young‐Ik;
Jeong, Han‐Sin;
Chung, Man Ki;
Hong, Sang Duk;
Ahn, Yong Chan;
Oh, Dong Ryul;
Noh, Jae Myoung;
Park, Keunchil;
Ahn, Myung‐Ju;
Kim, Hyung‐Jin;
Kim, Yi Kyung;
Ko, Young Hyeh

Publication type:

Article

Fate of patients with nasopharyngeal cancer who developed distant metastasis as first failure after definitive radiation therapy.

Published in:

Head & Neck, 2016, v. 38, p. E293, doi. 10.1002/hed.23988

By:

Chang, Ji Hyun;
Ahn, Yong Chan;
Park, Hyojung;
Oh, Dongryul;
Noh, Jae Myoung;
Sun, Jong ‐ Mu;
Ahn, Myung ‐ Ju;
Park, Keunchil

Publication type:

Article

Presence of anaplastic lymphoma kinase translocation in sarcomatoid carcinoma of head and neck and treatment effect of crizotinib: A case series.

Published in:

Head & Neck, 2015, v. 37, n. 5, p. E66, doi. 10.1002/hed.23884

By:

Kim, Sung Min;
Kim, Moon Jin;
Jung, Hyun Ae;
Sun, Jong‐Mu;
Choi, Yoon‐La;
Ko, Young‐Hyeh;
Park, Keunchil;
Baek, Chung‐Hwan;
Son, Young‐Ik;
Ahn, Myung‐Ju;
Irish, Jonathan

Publication type:

Article

Comprehensive Analysis of Mutation-Based and Expressed Genes-Based Pathways in Head and Neck Squamous Cell Carcinoma.

Published in:

Processes, 2021, v. 9, n. 5, p. 792, doi. 10.3390/pr9050792

By:

Keam, Bhumsuk;
Park, Jin-Young;
Kim, Jin-Pyo;
Kim, Gun-Do;
Yu, Yun-Suk;
Cho, Sang-Hee;
Kim, Sangwoo;
Ahn, Hee-Kyung;
Chun, Sang-Hoon;
Kwon, Jung-Hye;
Yun, Tak;
Kim, Ji-Won;
Kim, Ji-Eun;
Ahn, Myung-Ju;
Kim, Joo-Hang;
Yun, Hwan-Jung;
Kim, Bonglee

Publication type:

Article

Treatment and Outcomes of Metastatic Non-Small-Cell Lung Cancer Harboring Uncommon EGFR Mutations: Are They Different from Those with Common EGFR Mutations?

Published in:

Biology (2079-7737), 2020, v. 9, n. 10, p. 326, doi. 10.3390/biology9100326

By:

Jung, Hyun Ae;
Park, Sehhoon;
Sun, Jong-Mu;
Lee, Se-Hoon;
Ahn, Jin Seok;
Ahn, Myung-Ju;
Park, Keunchil

Publication type:

Article

A phase Ia/Ib study of novel anti‐ErbB3 monoclonal antibody, barecetamab (ISU104) in refractory solid cancers and monotherapy or in combination with cetuximab in recurrent or metastatic head and neck cancer.

Published in:

International Journal of Cancer, 2023, v. 153, n. 8, p. 1501, doi. 10.1002/ijc.34622

By:

Seo, Seyoung;
Keam, Bhumsuk;
Shin, Seong Hoon;
Chae, Yee Soo;
Kim, Tae Min;
Park, Lee Chun;
Hong, Seung‐Beom;
Ahn, Myung‐Ju;
Kim, Sung‐Bae

Publication type:

Article

Improved treatment outcome of pembrolizumab in patients with nonsmall cell lung cancer and chronic obstructive pulmonary disease.

Published in:

International Journal of Cancer, 2019, v. 145, n. 9, p. 2433, doi. 10.1002/ijc.32235

By:

Shin, Sun Hye;
Park, Hye Yun;
Im, Yunjoo;
Jung, Hyun Ae;
Sun, Jong‐Mu;
Ahn, Jin Seok;
Ahn, Myung‐Ju;
Park, Keunchil;
Lee, Ho Yun;
Lee, Se‐Hoon

Publication type:

Article

Prognostic value of FOXP3+ regulatory T cells for patients with locally advanced oropharyngeal squamous cell carcinoma.

Published in:

PLoS ONE, 2022, v. 17, n. 10, p. 1, doi. 10.1371/journal.pone.0274830

By:

Hur, Joon Young;
Ku, Bo Mi;
Park, Sehhoon;
Jung, Hyun Ae;
Lee, Se-Hoon;
Ahn, Myung-Ju

Publication type:

Article

Pembrolizumab for the treatment of non-small cell lung cancer.

Published in:

Expert Opinion on Biological Therapy, 2016, v. 16, n. 3, p. 397, doi. 10.1517/14712598.2016.1145652

By:

Lim, Sung Hee;
Sun, Jong-Mu;
Lee, Se-Hoon;
Ahn, Jin Seok;
Park, Keunchil;
Ahn, Myung-Ju

Publication type:

Article

Comparison of RECIST to immune-related response criteria in patients with non-small cell lung cancer treated with immune-checkpoint inhibitors.

Published in:

2017

By:

Kim, Hee;
Heo, Mi;
Lee, Han;
Sun, Jong-Mu;
Lee, Se-Hoon;
Ahn, Jin;
Park, Keunchil;
Ahn, Myung-Ju;
Kim, Hee Kyung;
Heo, Mi Hwa;
Lee, Han Sang;
Ahn, Jin Seok

Publication type:

journal article

A phase II trial of gefitinib monotherapy in pretreated patients with advanced non-small cell lung cancer not harboring activating EGFR mutations: implications of sensitive EGFR mutation test.

Published in:

Cancer Chemotherapy & Pharmacology, 2015, v. 75, n. 6, p. 1229, doi. 10.1007/s00280-015-2740-9

By:

Choi, Moon;
Hong, Jung;
Chang, Won;
Kim, Moon;
Kim, Sung;
Jung, Hyun;
Do, In-Gu;
Choi, Yoon-la;
Sun, Jong-Mu;
Ahn, Jin;
Park, Keunchil;
Ahn, Myung-Ju

Publication type:

Article

Safety and efficacy of gemcitabine or pemetrexed in combination with a platinum in patients with non-small-cell lung cancer and prior interstitial lung disease.

Published in:

Cancer Chemotherapy & Pharmacology, 2014, v. 73, n. 6, p. 1217, doi. 10.1007/s00280-014-2458-0

By:

Choi, Moon;
Hong, Jung;
Chang, Wonjin;
Kim, Moonjin;
Kim, Sungmin;
Jung, Hyun;
Lee, Su;
Park, Silvia;
Chung, Man;
Sun, Jong-Mu;
Park, Keunchil;
Ahn, Myung-Ju;
Ahn, Jin

Publication type:

Article

Is there any predictor for clinical outcome in EGFR mutant NSCLC patients treated with EGFR TKIs?

Published in:

Cancer Chemotherapy & Pharmacology, 2014, v. 73, n. 5, p. 1063, doi. 10.1007/s00280-014-2442-8

By:

Lee, Ji;
Lim, Sung;
Kim, Moonjin;
Kim, Sungmin;
Jung, Hyun;
Chang, Won;
Choi, Moon;
Hong, Jung;
Lee, Su;
Sun, Jong-Mu;
Ahn, Jin;
Park, Keunchil;
Ahn, Myung-Ju

Publication type:

Article

Efficacy of EGFR tyrosine kinase inhibitors for non-adenocarcinoma NSCLC patients with EGFR mutation.

Published in:

Cancer Chemotherapy & Pharmacology, 2012, v. 70, n. 2, p. 315, doi. 10.1007/s00280-012-1876-0

By:

Cho, Su-Hee;
Park, Lee;
Ji, Jun;
Park, Silvia;
Hwang, Deok;
Lee, Ji;
Choi, Yoon-La;
Han, Jung-Ho;
Sun, Jong-Mu;
Ahn, Jin;
Park, Keunchil;
Ahn, Myung-Ju

Publication type:

Article

Drug-induced interstitial lung disease in tyrosine kinase inhibitor therapy for non-small cell lung cancer: a review on current insight.

Published in:

Cancer Chemotherapy & Pharmacology, 2011, v. 68, n. 5, p. 1099, doi. 10.1007/s00280-011-1737-2

By:

Min, Ji;
Lee, Ho;
Lim, Hoyeong;
Ahn, Myung-Ju;
Park, Keunchil;
Chung, Man;
Lee, Kyung

Publication type:

Article

Safety and pharmacokinetics of intrathecal administration of pemetrexed in rats.

Published in:

Cancer Chemotherapy & Pharmacology, 2011, v. 68, n. 2, p. 531, doi. 10.1007/s00280-010-1522-7

By:

Sun, Jong-Mu;
Nam, Mi;
Chung, Jae;
Im, Bohee;
Lee, Soo-Youn;
Suh, Youn-Lim;
Ahn, Jin;
Park, Keunchil;
Ahn, Myung-Ju

Publication type:

Article